$38 million will fund rare disease research over four-year period
Research for rare diseases including ALS will be supported over the next four years by $38 million in FDA funding.
Stay updated with breaking news from Products Grants Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Research for rare diseases including ALS will be supported over the next four years by $38 million in FDA funding.
WASHINGTON (dpa-AFX) - The U.S. Food and Drug Administration has awarded 19 new grants and two new contracts totaling more than $38 million in funding mainly to develop medical products to treat
/PRNewswire/ -- Today, the U.S. Food and Drug Administration announced it has awarded 19 new grants and two new contracts totaling more than $38 million in...
NEW YORK CITY (dpa-AFX) - Bristol Myers Squibb's Orencia has received approval from the U.S. Food and Drug Administration for prophylaxis or prevention of acute graft versus host disease or aGVHD.This
/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Orencia (abatacept) for the prophylaxis (prevention) of acute graft versus host disease...